Form 4 for SHPH Shuttle Pharmaceuticals Holdings, Inc.
Accepted 2024-10-09 00:00:00 ET · period of report 2024-05-01 · accession 0001493152-24-040614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-09 | 2024-05-01 | SHPH | Jung Mira | CSO | A - Grant | $11.28 | -598 | 135.7K | -0.4% | -$6,745 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CLASS A COMMON STOCK | 2024-05-01 | A | D | 598 | $11.28 | 135,715 | D | — | — | (F1) The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024. (F2) Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024. |